HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lessons from the adjuvant bevacizumab trial on colon cancer: what next?

AuthorsEric Van Cutsem, Diether Lambrechts, Hans Prenen, Rakesh K Jain, Peter Carmeliet
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 29 Issue 1 Pg. 1-4 (Jan 01 2011) ISSN: 1527-7755 [Electronic] United States
PMID21115866 (Publication Type: Comment, Editorial)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Organoplatinum Compounds
  • Bevacizumab
  • Leucovorin
  • Fluorouracil
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Bevacizumab
  • Chemotherapy, Adjuvant
  • Clinical Trials, Phase III as Topic
  • Colonic Neoplasms (drug therapy)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Leucovorin (administration & dosage)
  • Male
  • Organoplatinum Compounds (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: